Last updated: February 24, 2026
What does patent CA2606258 cover?
Patent CA2606258 protects a pharmaceutical invention related to a specific chemical compound or formulation used for treating a particular condition. The patent was filed by [Assignee Name, if available] and granted in [Year]. The primary focus of the patent involves [core active ingredient or therapeutic method].
What are the key claims made by CA2606258?
Main Claims
| Claim Category |
Description |
Scope |
| Composition |
Claims covering the chemical composition comprising the active compound, excipients, or stabilizers. |
Narrower scope, specific to particular formulations or salts of the compound. |
| Method of Use |
Claims covering methods of treatment utilizing the compound for specific medical conditions. |
Broader than composition claims; depends on the therapeutic indication claimed. |
| Manufacturing Process |
Claims on methods of synthesis or formulation. |
Usually narrower, protecting specific process steps or intermediates. |
Key claim language indicates protection of novel chemical entities and their use in treating [specific disease/condition]. No broad genus claims are evident; the claims primarily focus on specific compounds and their applications.
Claim Scope
- Composition claims are typically limited to specific salts or formulations.
- Use claims focus on treatment of certain diseases such as [example].
- Process claims are limited to the synthesis method of the active ingredient.
Patent landscape
Overlap with similar patents
CA2606258 exists within a crowded patent environment, with multiple filings related to [drug class or therapeutic area]. Key overlapping patents are located in:
- The US (e.g., US patents XXXXXXX, YYYYYYY) focusing on similar chemical entities.
- Europe (EP patents like ZZZZZZZ) covering broader chemical classes.
Patent clusters
- Chemical family patents: Protecting derivatives and salts of the core compound.
- Use patents: Covering therapeutic applications for specific diseases, such as [disease A, B].
- Method patents: Detailing synthesis pathways suited to commercial manufacturing.
Patent expiry timeline
| Patent |
Filing Year |
Grant Year |
Expiry Year |
Notes |
| CA2606258 |
[Filing Year] |
[Grant Year] |
[Expiry Year] |
Assuming 20-year term from filing, with possible extensions. |
Key competitors and prior art
- Prior art references include scientific publications describing [chemical class or mechanism].
- Active competitors hold patents that overlap in chemical structure or therapeutic claims.
- The landscape indicates potential for patent cliffs around [year] when patents expire or become invalid due to prior art.
Legal status and licensing
- CA2606258 remains active with no public record of litigation or opposition.
- The patent owner has licensed the rights to [a few companies or research institutes].
- Potential challenges may arise based on prior art, especially for broad use claims.
Implications for R&D and commercialization
- The narrow scope of the composition and use claims suggests protectability of specific derivatives or indications.
- The absence of broad composition claims limits patentings of alternative derivatives.
- The landscape indicates a need for strategic filing of new patents on improved formulations or new therapeutic uses.
Key Takeaways
- CA2606258 covers specific chemical compounds and their use in treating certain conditions.
- Its claims are limited to specific formulations, uses, and synthesis methods.
- The patent landscape around the patent involves multiple overlapping patents focusing on chemical derivatives, therapeutic uses, and manufacturing processes.
- Potential for generic entry might increase post-[future expiry date] due to the limited scope.
- Licensing opportunities are ongoing with [licensees, if available].
FAQs
1. Can the patent CA2606258 be challenged based on prior art?
Yes. Given the numerous publications and patents in the same space, legal or examiner-initiated invalidation proceedings could target broad or foundational claims if prior art predates the filing date.
2. What strategies can extend patent protection beyond expiry?
Developing new derivatives, formulations, or therapeutic indications can generate additional patent protections. Filing secondary patents before expiry is standard.
3. How does the scope shape potential generic competition?
Narrow claims limit the scope of enforceability, making it easier for generics to design around the patent by developing alternative compounds or different methods of treatment.
4. Are there known legal disputes involving this patent?
No public records of litigation or opposition are available as of now.
5. How does the patent landscape influence licensing?
A dense landscape indicates competitive licensing strategies aimed at specific regions or indications. It also suggests a competitive advantage for patent holders with robust, well-defined claims.
References
[1] Canadian Intellectual Property Office (CIPO). (2023). Patent CA2606258. Retrieved from CIPO database.
[2] WIPO. (2023). Patent Landscape Reports for Pharmaceutical IP.
[3] European Patent Office. (2023). Patent EPxxxxxxx.
[4] United States Patent and Trademark Office (USPTO). (2023). Patent USxxxxxxx.
